Cited by 703Dementia and Cognitive Impairment ResearchAlzheimer's disease research and treatmentsCancer-related cognitive impairment studies

The DOI matches its Crossref record; 83 of the 83 references it cites were found in a registry or an index.

Multimodal techniques for diagnosis and prognosis of Alzheimer's disease

Open access

Perrin, Richard J., Fagan, Anne M., Holtzman, David M.·2009·Nature

DOI 10.1038/nature08538PMC PMC2810658

Open this paper in CoChat — free account

Abstract

Alzheimer's disease affects millions of people around the world. Currently, there are no treatments that prevent or slow the disease. Like other neurodegenerative diseases, Alzheimer's disease is characterized by protein misfolding in the brain. This process and the associated brain damage begin years before the substantial neurodegeneration that accompanies dementia. Studies using new neuroimaging techniques and fluid biomarkers suggest that Alzheimer's disease pathology can be detected preclinically. These advances should allow the design of new clinical trials and early mechanism-based therapeutic intervention.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1038/nature08538

Cites

83 of 83 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

The Amyloid Hypothesis of Alzheimer’s Disease: Progress and Problems on the Road to Therapeutics
Hardy, J., & Selkoe, D. J. (2002) · Science · doi:10.1126/science.1072994 · Cited by 13,864
Amyloid oligomers exacerbate tau pathology in a mouse model of tauopathy
Selenica, M.-L. B., Brownlow, M., Jimenez, J. P., Lee, D. C., Pena, G., Dickey, C. A., Gordon, M. N., & Morgan, D. (2013) · Neurodegenerative Diseases · doi:10.1159/000337230 · Cited by 10,359
The Clinical Dementia Rating (CDR): Current version and scoring rules
Morris, J. C. (1993) · Neurology · doi:10.1212/wnl.43.11.2412-a · Cited by 9,882
The Brain's Default Network: Anatomy, Function, and Relevance to Disease
Buckner, R. L., Andrews‐Hanna, J. R., & Schacter, D. L. (2008) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1440.011 · Cited by 9,761
Mild Cognitive Impairment: Clinical Characterization and Outcome
Petersen, R. C., Smith, G. E., Waring, S. C., Ivnik, R. J., Tangalos, E. G., & Kokmen, E. (1999) · Archives of Neurology · doi:10.1001/archneur.56.3.303 · Cited by 8,980
The Consortium to Establish a Registry for Alzheimer's Disease (CERAD): Part II. Standardization of the neuropathologic assessment of Alzheimer's disease
Mirra, S. S., Heyman, A., McKeel, D., Sumi, S. M., Crain, B. J., Brownlee, L. M., Vogel, F. S., Hughes, J. P., Belle, G. V., Berg, L., et al. (1991) · Neurology · doi:10.1212/wnl.41.4.479 · Cited by 4,961
Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound‐B
Klunk, W. E., Engler, H., Nordberg, A., Wang, Y., Blomqvist, G., Holt, D. P., Bergström, M., Savitcheva, I., Huang, G., Estrada, S., et al. (2004) · Annals of Neurology · doi:10.1002/ana.20009 · Cited by 4,496
Searching for a baseline: Functional imaging and the resting human brain
Gusnard, D. A., & Raichle, M. E. (2001) · Nature Reviews Neuroscience · doi:10.1038/35094500 · Cited by 3,371
Consortium to Establish a Registry for Alzheimer's Disease (CERAD)
Fillenbaum, G., & Heyman, A. (2002) · doi:10.1002/0470846410.ch42(iii · Cited by 2,859
Diagnosis of Alzheimer's Disease
Khachaturian, Z. S. (1985) · Archives of Neurology · doi:10.1001/archneur.1985.04060100083029 · Cited by 2,499

Show all 83 references

Research works printed but not linked: 3

Alzheimer, A. About a peculiar disease of the cerebral cortex [translation]. Alzheimer Dis. Assoc. Disord. 1, 7–8 (1987).
Morris J. C. et al. PIB imaging predicts progression to symptomatic Alzheimer's disease. Arch. Neurol. (in the press).
Cairns, N. J. et al. PiB-PET detection of cerebral Aβ may lag clinical, cognitive, and CSF markers of Alzheimer's disease: a case report. Arch. Neurol. (in the press).

Sorted by citations

Items 501–600 of 703

Adrenergic β receptor activation in the basolateral amygdala, which is intracellular Zn2+-dependent, rescues amyloid β1-42-induced attenuation of dentate gyrus LTP
Tamano, H., Kubota, M., Fujise, Y., Shimaya, R., Itoh, R., Suzuki, M., Adlard, P. A., Bush, A. I., & Takeda, A. (2018) · Neurochemistry International · doi:10.1016/j.neuint.2018.07.005 · Cited by 6
Adrenergic β receptor activation reduces amyloid β1-42-mediated intracellular Zn2+ toxicity in dentate granule cells followed by rescuing impairment of dentate gyrus LTP
Tamano, H., Ishikawa, Y., Shioya, A., Itoh, R., Oneta, N., Shimaya, R., Egawa, M., Adlard, P. A., Bush, A. I., & Takeda, A. (2020) · NeuroToxicology · doi:10.1016/j.neuro.2020.06.001 · Cited by 6
Novel strategies for the fight of Alzheimer’s disease targeting amyloid-β protein
Xie, Y., Wang, Y., Jiang, S., Xiang, X., Wang, J., & Ning, L. (2021) · Journal of drug targeting · doi:10.1080/1061186x.2021.1973482 · Cited by 6
TIA1 Mediates Divergent Inflammatory Responses to Tauopathy in Microglia and MacrophagesPreprint
Webber, C. J., van der Spek, S. J. F., Cruz, A. L., Puri, S., Zhang, C., Aw, J. T. M., Papadimitriou, G.-Z., Roberts, R., Jiang, K., Tran, T., et al. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.11.06.622325 · Cited by 6
Multi-view reject inference for semi-supervised credit scoring with consistency training and three-way decision
Tang, H., & Liang, D. (2025) · Omega · doi:10.1016/j.omega.2025.103280 · Cited by 5
Detection of Alzheimer’s Disease Using a Four-Channel EEG Montage
Perez‐Valero, E., Minguillón, J., Morillas, C. A., Pelayo, F. J., & López-Gordo, M. A. (2022) · Lecture notes in computer science · doi:10.1007/978-3-031-06242-1_43 · Cited by 5
Intranasal Delivery of Metabolically Resilient Glutathione: In Vivo Pharmacokinetic, Permeation, and Efficacy Studies
Bhilare, K. D., Dobariya, P., Lee, A., Xie, W., Xie, J., Meints, J. P., Vince, R., Lee, M. K., & More, S. S. (2025) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.5c00382 · Cited by 5
Kinetics of amyloid accumulation in physiological viscosity
Kuragano, M., Yamanaka, S., & Tokuraku, K. (2022) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2022.112449 · Cited by 5
Neuroimaging and clinical characteristics of cognitive migration in community-dwelling older adults
Duran, T., Bateman, J. R., Williams, B. J., Espeland, M. A., Hughes, T. M., Okonmah‐Obazee, S. E., Rundle, M. M., Craft, S., & Lockhart, S. N. (2022) · NeuroImage Clinical · doi:10.1016/j.nicl.2022.103232 · Cited by 6
Molecular Integrative Analysis of the Inhibitory Effects of Dipeptides on Amyloid β Peptide 1–42 Polymerization
Yuan, N., Ye, L., Sun, Y. P., Wu, H., Xiao, Z., Fu, W., Chen, Z., Pei, Y., Min, Y., & Wang, D. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24087673 · Cited by 5
Robust Prior Stage Epileptic Seizure Diagnosis System using Resnet and Backpropagation Techniques
Priti, N. (2020) · International Journal of Emerging Trends in Engineering Research · doi:10.30534/ijeter/2020/120852020 · Cited by 5
Heptameric Peptide Interferes with Amyloid-β Aggregation by Structural Reorganization of the Toxic Oligomers
Bhattacharyya, R., Bhattacharjee, S., Pathak, B. K., & Sengupta, J. (2020) · ACS Omega · doi:10.1021/acsomega.0c01730 · Cited by 5
Heterogeneity of Cerebrospinal Fluid Biomarkers Profiles in Individuals with Distinct Levels of Cognitive Decline: A Cross-Sectional Study
Pais, M. V., Loureiro, J. C., do Vale, V. S., Radanovic, M., Talib, L. L., Stella, F., & Forlenza, O. V. (2021) · Journal of Alzheimer s Disease · doi:10.3233/jad-210144 · Cited by 5
The role of amyloid beta 4-42 in the etiology of Alzheimer's disease
Bouter, Y. (2015) · eDiss (Georg-August-Universität Göttingen) · doi:10.53846/goediss-4849 · Cited by 5
Unlocking POCT potential: Multifunctional nano-enhanced lateral flow immunoassay for multiplexed detection of Alzheimer's disease biomarkers in diverse biological fluids
Chen, S., Li, C., Zhang, C., Zhao, S., Wang, Y., & Liu, Q. (2025) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2025.217551 · Cited by 4
Precision medicines for the treatment of Alzheimer's disease
Kanthale, S. B., Kendre, P. N., Vibhute, S. K., Jain, S. P., & Tiwari, S. S. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-13205-6.00025-x · Cited by 4
Disruption of sphingomyelin synthase 2 gene alleviates cognitive impairment in a mouse model of Alzheimer’s disease
Uchiumi, O., Zou, J., Yamaki, S., Hori, Y., Ono, M., Yamamoto, R., & Kato, N. (2024) · Brain Research · doi:10.1016/j.brainres.2024.148934 · Cited by 4
2-Phenylbenzothiazolyl iridium complexes as inhibitors and probes of amyloid β aggregation
Terpstra, K., Huang, Y., Na, H., Sun, L., Gutierrez, C., Yu, Z., & Mirica, L. M. (2024) · Dalton Transactions · doi:10.1039/d4dt01691b · Cited by 4
Recurrence quantification analysis of rs-fMRI data: A method to detect subtle changes in the TgF344-AD rat model
Rezaei, A., van den Berg, M., Mirlohi, H., Verhoye, M., Amiri, M., & Keliris, G. A. (2024) · Computer Methods and Programs in Biomedicine · doi:10.1016/j.cmpb.2024.108378 · Cited by 4
Genetics of Alzheimer’s Disease: Lessons Learned in Two Decades
Taner, N. (2010) · DOAJ (DOAJ: Directory of Open Access Journals) · Cited by 4
Biomathematical screening of amyloid radiotracers with clinical usefulness index
Nai, Y., Shidahara, M., Seki, C., & Watabe, H. (2017) · Alzheimer s & Dementia Translational Research & Clinical Interventions · doi:10.1016/j.trci.2017.08.006 · Cited by 4
Isoproterenol injected into the basolateral amygdala rescues amyloid β1-42-induced conditioned fear memory deficit via reducing intracellular Zn2+ toxicity
Ishikawa, Y., Itoh, R., Tsujimoto, R., Tamano, H., & Takeda, A. (2021) · Neuroscience Letters · doi:10.1016/j.neulet.2021.136353 · Cited by 4
Investigation of the quantitative accuracy of low-dose amyloid and tau PET imaging
Nai, Y., Watanuki, S., Tashiro, M., Okamura, N., & Watabe, H. (2018) · Radiological Physics and Technology · doi:10.1007/s12194-018-0485-y · Cited by 4
Photoluminescent Response of Poly(3‐methylthiophene)‐DNA Single Nanowire Correlating to Nucleotide‐Mismatch Locus in DNA–DNA Hybridization
Park, D. H., Cui, C., & Ahn, D. J. (2020) · Macromolecular Rapid Communications · doi:10.1002/marc.202000164 · Cited by 4
Boosting the Photodynamic Degradation of Islet Amyloid Polypeptide Aggregates Via a “Bait-Hook-Devastate” Strategy
Cao, Y., He, Z., Gao, Y., Xin, Y., Luo, L., & Meng, F. (2021) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.1c00082 · Cited by 4
Patterns of Focal Amyloid Deposition Using 18F-Florbetaben PET in Patients with Cognitive Impairment
Chung, S.-E., Kim, H., Jo, S., Lee, S., Lee, Y., Roh, J. H., & Lee, J. (2022) · Diagnostics · doi:10.3390/diagnostics12061357 · Cited by 4
Targeted Metabolomic Analysis of the Eye Tissue of Triple Transgenic Alzheimer’s Disease Mice at an Early Pathological Stage
Shen, L., Tang, X., Zhang, H., Zhuang, H., Jing, L., Zhao, Y., & Liu, X. (2023) · Molecular Neurobiology · doi:10.1007/s12035-023-03533-2 · Cited by 4
Biomarker Modelling of Early Molecular Changes in Alzheimer’s Disease
Paterson, R. W., Toombs, J., Slattery, C. F., Schott, J. M., & Zetterberg, H. (2013) · Molecular Diagnosis & Therapy · doi:10.1007/s40291-013-0069-9 · Cited by 5
Acupuncture targeting and regulating multiple signaling pathways related to Zusanli acupoint using iTRAQ-based quantitative proteomic analysis
Sun, H. J., Zhang, A., Yan, G., Zhang, Y., Meng, X., Li, L., Xie, N., Cheng, W., & Wang, X. (2014) · Acupuncture and Related Therapies · doi:10.1016/j.arthe.2014.03.002 · Cited by 4
Advances in Retinal Imaging: Retinal Amyloid Imaging
Koronyo‐Hamaoui, M., Doustar, J., Oviatt, M., Black, K. L., & Koronyo, Y. (2020) · Springer eBooks · doi:10.1007/978-3-030-26269-3_6 · Cited by 4
Emerging Therapeutic Strategies in Alzheimer's Disease
Chiba, T. (2013) · InTech eBooks · doi:10.5772/55293 · Cited by 5
Biomarkers of Alzheimer’s disease
Bos (2018) · Research Publications (Maastricht University) · doi:10.26481/dis.20181012ib · Cited by 4
Generating MRI ‐Derived CSF Proxy‐Markers to Predict and Visualize Alzheimer's Disease Progression
Abrol, A., Calhoun, V. D., & Initiative, T. A. D. N. (2025) · Human Brain Mapping · doi:10.1002/hbm.70391 · Cited by 3
A survey of multimodal fusion for Alzheimer’s disease prediction: A new taxonomy and trends
Guan, Y., Wang, W., Chen, J., Yang, P., Xu, J., & Qi, J. (2025) · Information Fusion · doi:10.1016/j.inffus.2025.104098 · Cited by 3
ACR–ACNM–ASNR–SNMMI Practice Parameter for the Performance of Brain PET/CT Imaging in Dementia
Tu, R. K., Esposito, G., Agarwal, A., Akin, E. A., Catana, C., Chiang, G. C.-Y., Colletti, P. M., Dhingra, J., Kuo, P. H., Franceschi, A. M., et al. (2026) · American Journal of Neuroradiology · doi:10.3174/ajnr.a9105 · Cited by 3
Systemic complement factors in aging, Alzheimer’s disease and other dementias: a longitudinal study over 10 years
Fu, X., Cai, H., Quan, S., Zhang, W., Geng, Y., Tian, Q., Ren, Z., Xu, Y., An, C., Li, J., et al. (2026) · Molecular Neurodegeneration · doi:10.1186/s13024-026-00927-3 · Cited by 3
Visual disorders and driving ability in persons with dementia: A mini review
Papageorgiou, E., Tsirelis, D., Lazari, K., Siokas, V., Dardiotis, E., & Tsironi, E. E. (2022) · Frontiers in Human Neuroscience · doi:10.3389/fnhum.2022.932820 · Cited by 3
Evaluating the feasibility of cognitive impairment detection in Alzheimer’s disease screening using a computerized visual dynamic test
Perez‐Valero, E., Morillas, C. A., López-Gordo, M. A., & Alcalde, S. L. (2023) · Journal of NeuroEngineering and Rehabilitation · doi:10.1186/s12984-023-01155-2 · Cited by 3
Les marqueurs de la maladie d’Alzheimer prodromale
de Souza, L. C., Sarazin, M., Uspenskaya, O., Habert, M., Lamari, F., Lehéricy, S., & Dubois, B. (2012) · Revue Neurologique · doi:10.1016/j.neurol.2012.07.005 · Cited by 6
alzheimer disease: New Concepts on Its Neurobiology and the Clinical
Jack, C. R., & Cme, O. (2012) · Cited by 3
Alzheimer's Disease Longitudinal Change in CSF Biomarkers in Autosomal-Dominant
Fagan, A. M. (2014) · Cited by 3
Self-citation
Multi-class Recognition of Alzheimer’s and Parkinson’s diseases using Bag of Deep reduced Features (BoDrF) with Improved Chaotic Multi Verse Harris Hawks Optimization (CMVHHO) and Random Forest (RF) based classification for early diagnosis
Balaji, C., & Suresh, D. S. (2022) · Computer Methods in Biomechanics and Biomedical Engineering Imaging & Visualization · doi:10.1080/21681163.2022.2111721 · Cited by 3
Spatiotemporal development of the neuronal accumulation of amyloid precursor protein and the amyloid plaque formation in the brain of 3xTg-AD mice
Ono, M., Ito, T., Yamaki, S., Hori, Y., Zhou, Q., Zhao, X., Muramoto, S., Yamamoto, R., Furuyama, T., Sakata‐Haga, H., et al. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e28821 · Cited by 3
Data-driven separation and estimation of atrial dynamics in very high-dimensional electrocardiograms from epilepsy patients
Stamoulis, C., Connoly, J., & Duffy, F. H. (2019) · Annual International Conference of the IEEE Engineering in Medicine and Biology Society (EMBC) · doi:10.1109/embc.2019.8856494 · Cited by 3
Paradigmawechsel zugunsten einer besseren oralen Gesundheit im Alter
Besimo, C. (2015) · SWISS DENTAL JOURNAL SSO – Science and Clinical Topics · doi:10.61872/sdj-2015-05-05 · Cited by 3
Neuronal Networks and Therapeutics in Neurodegenerative Disorders
Lakraj, A. A., Jabbari, B., & Machado, D. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-415804-7.00025-3 · Cited by 3
Computer-aided diagnostic reporting of FDG PET for the diagnosis of Alzheimer’s disease
Prestia, A., Muscio, C., Caroli, A., & Frisoni, G. B. (2013) · Clinical and Translational Imaging · doi:10.1007/s40336-013-0031-1 · Cited by 3
Stealth Attack: Plaque-Specific Antibody Allows for Efficient Aβ Removal without Side Effects
Roh, J. H., & Holtzman, D. M. (2012) · Neuron · doi:10.1016/j.neuron.2012.11.018 · Cited by 3
Self-citation
Are Inflammatory Profiles the Key to Personalized Alzheimer's treatment?
Brothers, H. M., & Wilcock, D. M. (2013) · Neurodegenerative Disease Management · doi:10.2217/nmt.13.40 · Cited by 3
Performance Evaluation of Bacterial Foraging Optimization Algorithm for the Early Diagnosis and Tracking of Alzheimer’s Disease
Varghese, T., Kumari, R. S., Mathuranath, P. S., & Singh, N. (2012) · Lecture notes in computer science · doi:10.1007/978-3-642-35380-2_6 · Cited by 3
Comparison of Cerebrospinal Fluid Amyloidogenic Nanoplaques With Core Biomarkers of Alzheimer’s Disease
Aksnes, M., Tiiman, A., Edwin, T. H., Terenius, L. Y., Bogdanović, N., Vukojević, V. B., & Knapskog, A. (2021) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2020.608628 · Cited by 3
CSF Biomarkers for Secondary Prevention Trials
Holtzman, D. M. (2012) · Archives of Neurology · doi:10.1001/archneurol.2012.587 · Cited by 3
Self-citation
Advanced Polymeric Nanoparticles for the Treatment of Neurodegenerative Diseases
Ferrão, R., & Rai, A. (2024) · Wiley eBooks · doi:10.1002/9783527837021.ch27 · Cited by 3
Immunotherapies: A Treasure Trove of Alzheimer's Disease
Kolay, A., Neelam, N., Gupta, P., Shaikh, A. M., Goel, R., Nagpal, D., & Chitme, H. R. (2024) · Current Pharmaceutical Biotechnology · doi:10.2174/0113892010308600240709052539 · Cited by 2
Identifying suppressive factors of Alzheimer’s disease through comprehensive analysis of real-world data: a single-center retrospective study
Shiotani, M., Hyohdoh, Y., Hatakeyama, Y., Kazui, H., & Okuhara, Y. (2025) · BMC Geriatrics · doi:10.1186/s12877-025-05982-x · Cited by 2
Ketone monoester alleviates cognitive impairment in a transgenic mouse model of Alzheimer’s disease through innate immunological IFITM3 pathway
Zhang, T., Ruan, J., Liu, Z., Yu, Y., Lü, Y., Zhang, X., Hou, C., Liu, X., Yuan, Y., & Han, X. (2025) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2025.106094 · Cited by 2
Explainable AI for MRI Alzheimer’s disease classification: A comparative analysis
Persson, S., Svenberg, H. E. A., Moscoso, A., Ferreira, D., & Moreno, R. (2026) · NeuroImage · doi:10.1016/j.neuroimage.2026.122043 · Cited by 3
Progress on Aβ-Targeted Therapeutic Strategies for Alzheimer′s Disease*
Hua, Q., Ding, H., & Liang, M. (2012) · PROGRESS IN BIOCHEMISTRY AND BIOPHYSICS · doi:10.3724/sp.j.1206.2012.00215 · Cited by 2
Alzheimer Hastalığının Erken Teşhisinin Çoklu Değişken Kullanarak Tespiti
Ergen, B., & Sertkaya, M. E. (2022) · European Journal of Science and Technology · doi:10.31590/ejosat.1082297 · Cited by 2
Neurophysiologische Untersuchungsmethoden in der Psychiatrie
Pogarell, O. M., & Hegerl, U. (2015) · Springer eBooks · doi:10.1007/978-3-642-45028-0_28-1 · Cited by 2
Fustin, a Potent Phytochemical, Attenuates Scopolamine-induced Memory Impairment and Neurodegeneration by Modulating Neuroinflammation and Neurotransmitters
Jambi, E. J., Afzal, M., Al-Abbasi, F. A., Moglad, E. H. O., Al-Qahtani, S. D., Almalki, N. A. R., Alzarea, S. I., Imam, F., Sayyed, N., & Kazmi, I. A. (2024) · Current Medicinal Chemistry · doi:10.2174/0109298673330002241015085330 · Cited by 2
Is there a link between the sleep–wake cycle and Alzheimer’s pathology?
Roh, J. H., & Holtzman, D. M. (2015) · Future Neurology · doi:10.2217/fnl.15.15 · Cited by 2
Self-citation
Prospects of Statistical and Biostatistical Techniques in the Study of Diagnosis, Survival Analysis, and Disease Progression of Alzheimer’s Disease
Deo, V. (2018) · Biostatistics and Biometrics Open Access Journal · doi:10.19080/bboaj.2018.07.555712 · Cited by 2
Q-well-posedness of an Aβ-protein polymerization model
Gueye, C., Ciuperca, I. S., Pujo-Menjouet, L., & Tine, L. M. (2023) · Mathematical Modelling of Natural Phenomena · doi:10.1051/mmnp/2023028 · Cited by 2
Comprehensive evaluation of early-phase FP-CIT PET as a substitute for brain FDG PET in parkinsonism
Son, H. J., Kim, C., & Choi, H. J. (2025) · Computers in Biology and Medicine · doi:10.1016/j.compbiomed.2025.110177 · Cited by 2
Multilayer Integration of Networks Toolbox (MINT)
Sarraf, S., Avelar‐Pereira, B., Hosseini, S. M. H., & Initiative, A. D. N. (2025) · Communications Biology · doi:10.1038/s42003-025-08269-4 · Cited by 2
Neurophysiologische Untersuchungsmethoden
Pogarell, O. M., & Hegerl, U. (2011) · Springer eBooks · doi:10.1007/978-3-642-03637-8_25 · Cited by 2
CDiP technology for reverse engineering of sporadic Alzheimer’s disease
Kondo, T., Yada, Y., Ikeuchi, T., & Inoue, H. (2022) · Journal of Human Genetics · doi:10.1038/s10038-022-01047-8 · Cited by 2
Preclinical models of Alzheimer’s disease for identification and preclinical validation of therapeutic targets: from fine-tuning strategies for validated targets to new venues for therapy
Vasconcelos, B., Bird, M., Stancu, I., Terwel, D., & Dewachter, I. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-805120-7.00006-3 · Cited by 2
Facile synthesis of stilbene-derivatized Schiff base ligands and their Cu(II) complexes
Uehara, D., & Salas, P. F. (2023) · Tetrahedron Letters · doi:10.1016/j.tetlet.2023.154406 · Cited by 2
Cerebrospinal Fluid Biomarkers for Clinical Trials
Perrin, R. J. (2012) · Archives of Neurology · doi:10.1001/archneurol.2012.2353 · Cited by 2
Self-citation
Neuroinflammation in depression
Dobos, N. (2014) · University of Groningen research database (University of Groningen / Centre for Information Technology) · Cited by 2
Amphiphilic Distyrylbenzene Derivatives as Potential Therapeutic and Imaging Agents for the Soluble Amyloid-β Oligomers in Alzheimer’s DiseasePreprint
Sun, L., Cho, H., Sen, S., Arango, A. S., Huynh, T. T., Huang, Y., Bandara, N., Rogers, B. E., Tajkhorshid, E., & Mirica, L. M. (2021) · ChemRxiv · doi:10.26434/chemrxiv.13605998 · Cited by 2
Detection of Alzheimer's disease using 3D-CNN model based on multimodal connectome
Dana, A. M. A., Karami, M., & Ghasemi, J. (2025) · Applied Soft Computing · doi:10.1016/j.asoc.2025.114006 · Cited by 1
A Cerebral Origin for Retinal Degeneration in the Visual Form of Alzheimer's Disease?
Jurkiewicz, T., Lehingue, E., Formaglio, M., Kuzdzal, D., Verrecchia, S., Pisella, L., & Tilikete, C. (2025) · European Journal of Neuroscience · doi:10.1111/ejn.70319 · Cited by 1
CEREBROSPINAL FLUID BIOMARKERS IN ALZHEIMER'S DISEASE: ARE THE HYPOTHESES MORE DYNAMIC THAN THE BIOMARKERS?
Spies, P. E., Verbeek, M. M., Rikkert, M. G. M. O., & Claassen, J. A. H. R. (2010) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.2010.03001.x · Cited by 1
Amyloid imaging in dementia
Ashraf, A., Mehta, P. D., & Edison, P. (2012) · Reviews in Clinical Gerontology · doi:10.1017/s0959259812000160 · Cited by 1
Risikomanagement im Alter durch frühzeitiges Erkennen von Erkrankungen
Besimo, C. (2015) · Der MKG-Chirurg · doi:10.1007/s12285-014-0451-6 · Cited by 1
Neurophysiologische Untersuchungsmethoden in der Psychiatrie
Pogarell, O. M., & Karch, S. (2017) · Springer Reference Medizin · doi:10.1007/978-3-642-45028-0_28-2 · Cited by 1
Theranostic nanoagents: Future of personalized nanomedicine
Sabale, V., Dubey, S., & Sabale, P. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-89839-3.00017-8 · Cited by 1
Computer-Based Assessment of Alzheimer’s Disease Employing fMRI and/or EEG: A Comprehensive Review
Tripoliti, E. E., Zervakis, M. E., & Fotiadis, D. I. (2014) · Neuromethods · doi:10.1007/7657_2014_70 · Cited by 1
Age‐related cognitive impairment is associated with low serum concentrations of testosterone and CSF levels of amyloid beta 42 in male cynomolgus monkeys (Macaca fascicularis)
Darusman, H. S., Wern, T. L., Sajuthi, D., Schapiro, S. J., & Hau, J. (2021) · Journal of Medical Primatology · doi:10.1111/jmp.12536 · Cited by 1
Modeling Amyloid Disease in Drosophila melanogaster
Berg, I. (2010) · KTH Publication Database DiVA (KTH Royal Institute of Technology) · Cited by 1
Ancestralidade da população de São Paulo e correlação com alterações neuropatológicas no idoso
Schlesinger, D. (2010) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.41.2010.tde-17122010-142628 · Cited by 1
Biomarkers in Alzheimer's Disease and Lewy Body Disorders with Dementia
Leyhe, T., Darreh‐Shori, T., Laske, C., Mielke, M. M., & Maetzler, W. (2013) · International Journal of Alzheimer s Disease · doi:10.1155/2013/473181 · Cited by 1
Chemistry of Alzheimer Disease
Sack, G. H. (2013) · Elsevier eBooks · doi:10.1016/b978-0-12-378630-2.00032-3 · Cited by 1
Evaluation of a cognitive and a morphometric marker for the early detection of Alzheimer's disease
Kälin, A. M. (2015) · Zurich Open Repository and Archive (University of Zurich) · doi:10.5167/uzh-117647 · Cited by 1
Graphene‐Based Materials for Brain Targeting
Aderibigbe, B. A., Naki, T., & Owonubi, S. J. (2019) · Wiley eBooks · doi:10.1002/9781119468455.ch120 · Cited by 1
Will Multi-modal Data Improves Few-shot Learning?Preprint
Zhang, Z., Ma, S., & Zhang, Y. (2021) · arXiv (Cornell University) · doi:10.48550/arxiv.2107.11853 · Cited by 1
Modeling the impact of genotype, age, sex, and continuous navigation on pathway integration performancePreprint
Pink, D., Ilkel, E., Chandreswaran, V., Moser, D., Getzmann, S., Gajewski, P. D., Axmacher, N., & Zhang, H. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.09.11.556925 · Cited by 2
Alzheimer's disease neurotoxic peptides : towards a comprehension of their modes of action on model membranes.
Azouz, M. (2019) · theses.fr (ABES) · doi:10.70675/4c3b6c12z1da5z497cz9e34zea6e6bf189d9 · Cited by 1
An investigation into the combined effects of β-amyloid toxicity and cerebral ischemia on the pathological expression of gangliosides.
Hepburn, J. D. (2012) · Scholarship@Western (Western University)
The dynamic nature of amyloid-beta protein aggregation and its association to Alzheimer’s disease
Vilaprinyó-Pascual, S. (2015) · Tesis Doctorals en Xarxa (Consorci de Serveis Universitaris de Catalunya)
Genetically Determined Hypometabolism in Alzheimer’s Disease and Midlife Risk Factors for Cognitive Impairment
Virta, J. J. (2012) · UTUPub (University of Turku)
The Role of Apolipoprotein E Concentration and Isoform in Amyloid-beta Metabolism In Vivo
Castellano, J. M. (2011) · Open Scholarship Institutional Repository (Washington University in St. Louis) · doi:10.7936/k7416v3s
Cytotoxic properties of amyloidogenic L68Q cystatin C. A search for therapeutic agents
Ingólfsdóttir, I. E. (2013)
Coding and Non-Coding RNA in Age-Associated Memory Impairment and Alzheimer's Disease
Rao, P. (2014) · eDiss (Georg-August-Universität Göttingen) · doi:10.53846/goediss-4498
Identification of Novel Fluid Biomarkers for Alzheimer's Disease
Craig‐Schapiro, R. (2012) · Open Scholarship Institutional Repository (Washington University in St. Louis) · doi:10.7936/k7pr7t12
Mechanisms of Brain Region-Specific Amyloid-beta Deposition
Bero, A. W. (2011) · Open Scholarship Institutional Repository (Washington University in St. Louis) · doi:10.7936/k7cj8bh2
Expression and characterisation of cardiovascular amyloid proteins
Davies, H. A. (2013) · doi:10.17638/00012075

Authors: Perrin, R. J., Fagan, A. M., & Holtzman, D. M.
Affiliations: Washington University in St. Louis (US)
ORCID: Perrin, Richard J.
Fagan, Anne M.
Holtzman, David M.
Venue: Nature
Publisher: Springer Science and Business Media LLC
Published: 2009-10
Volume: 461
Issue: 7266
Pages: 916-922
ISSN: 0028-0836 (ISSN-L)
1476-4687
DOI: 10.1038/nature08538
PMC: PMC2810658
OpenAlex: W2085558649
Cited by: 702
References: 83
Citations by year: 2026: 20 · 2025: 29 · 2024: 30 · 2023: 28 · 2022: 43 · 2021: 56 · 2020: 38 · 2019: 38 · 2018: 36 · 2017: 48 · 2016: 33 · 2015: 49 · 2014: 53 · 2013: 58 · 2012: 60
FWCI: 5.97
Type: journal article
Language: en
Open access: green
www.ncbi.nlm.nih.gov
Licence: www.springer.com/tdm (tdm)
Locations: Nature (publishedVersion)
PubMed (publishedVersion)
PubMed Central (acceptedVersion)
RePEc: Research Papers in Economics (submittedVersion)
Funders: National Institutes of Health (5t32ns007205-32)
National Institute on Aging (P50AG005681, P01 AG0 3991, P01AG003991, P50AG00568125, P01AG026276)
National Institute of Neurological Disorders and Stroke (T32-NS007205)
Topics: Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
Health Sciences › Medicine › Oncology › Cancer-related cognitive impairment studies
Keywords: Alzheimer's disease, multimodal diagnosis, prognosis, neuroimaging, fluid biomarkers, preclinical detection, protein misfolding, neurodegeneration, dementia, clinical trials
MeSH terms: Alzheimer Disease, Humans, Inflammation, Prognosis, Amyloid beta-Peptides, tau Proteins, Oxidative Stress, Proteomics

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Multimodal techniques for diagnosis and prognosis of Alzheimer's disease

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks